Cargando…
Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites
Both cirrhosis and diabetes are established risk factors for infections. However, it remains uncertain whether diabetes adds to the risk of infections in patients with cirrhosis who are already at high risk of infections, or increases the mortality following an infection. To answer these questions,...
Autores principales: | Bossen, Lars, Dam, Gitte A., Vilstrup, Hendrik, Watson, Hugh, Jepsen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001534/ https://www.ncbi.nlm.nih.gov/pubmed/32039377 http://dx.doi.org/10.1016/j.jhepr.2019.07.008 |
Ejemplares similares
-
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study
por: Jensen, Morten Daniel, et al.
Publicado: (2023) -
Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022) -
The impact of oral diseases in cirrhosis on complications and mortality
por: Ladegaard Grønkjær, Lea, et al.
Publicado: (2021) -
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
por: Jepsen, Peter, et al.
Publicado: (2016) -
No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis – A Danish Nationwide Cohort Study
por: Deleuran, Thomas, et al.
Publicado: (2016)